1 (Irinotecan, CPT-11) Oncologic Drugs Advisory Committee Review March 16, 2000 Camptosar Pharmacia & Upjohn First-Line Therapy of Metastatic Colorectal.
UNANSWERED QUESTIONS IN UPFRONT THERAPY CHEMOTHERAPY ISSUES: WEEKLY DOSING Andrés Poveda, MD Fundación Instituto Valenciano de Oncología [email protected].
Johanna Bendell, MD Director, GI Oncology Research Associate Director, Drug Development Unit
ABSTRACT
A Phase II Trial of Sunitinib (S) in Previously-Treated Pancreas Adenocarcinoma (PAC), CALGB 80603 E.M. O’Reilly, D. Niedzwiecki, D. Hollis, T. Bekaii-Saab,
Second Line Treatment for Gastroesophageal Cancers: Are We Helping People Feel Better and Live Longer? Johanna Bendell, MD Director, GI Oncology Research.
Future Perspectives in Anti-Angiogenic Therapy for Advanced Stage and Adjuvant CRC Lee M. Ellis, MD Departments of Cancer Biology and Surgical Oncology.
Neoadjuvant Chemotherapy in Ovarian Cancer
Efficacy of FOLFIRI-3 or other irinotecan-based regimens
Dual Phase Steel
Neoadjuvant Chemotherapy in Ovarian Cancer Key issues in trial design.
Image Processing on Line A new way to publish? A new way to organize research in a lab? Jérôme Darbon (UCLA and ENS Cachan), Nicolas Limare (ENS Cachan),
